{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T10:28:47Z","timestamp":1785148127820,"version":"3.55.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Headache Pain"],"DOI":"10.1186\/s10194-025-02219-5","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T10:46:29Z","timestamp":1764153989000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Clinical characteristics and social burden of menstrual migraine in Japan: an online-based cross-sectional questionnaire study"],"prefix":"10.1186","volume":"26","author":[{"given":"Tsubasa","family":"Takizawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko","family":"Ihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2341-3601","authenticated-orcid":false,"given":"Reiko","family":"Yoshikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanae","family":"Togo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Kitano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Iijima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,26]]},"reference":[{"key":"2219_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/0333102417738202","volume":"38","author":"IHS","year":"2018","unstructured":"IHS (2018) Headache Classification Committee of the International Headache Society (IHS) the International Classification of Headache Disorders, 3rd edition. Cephalalgia 38:1\u2013211. https:\/\/doi.org\/10.1177\/0333102417738202.","journal-title":"Cephalalgia"},{"key":"2219_CR2","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1080\/03007995.2021.1971179","volume":"37","author":"K Hirata","year":"2021","unstructured":"Hirata K, Ueda K, Komori M et al. (2021) Comprehensive population-based survey of migraine in Japan: results of the ObserVational survey of the epidemiology, tReatment, and care of MigrainE (OVERCOME [Japan]) study. Curr Med Res Opin 37:1945\u20131955. https:\/\/doi.org\/10.1080\/03007995.2021.1971179.","journal-title":"Curr Med Res Opin"},{"key":"2219_CR3","doi-asserted-by":"publisher","unstructured":"Igarashi H, Ueda K, Jung S et al. (2020) Social burden of people with the migraine diagnosis in Japan: evidence from a population-based cross-sectional survey. BMJ Open 10. https:\/\/doi.org\/10.1136\/bmjopen-2020-038987.","DOI":"10.1136\/bmjopen-2020-038987"},{"key":"2219_CR4","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1212\/WNL.53.1.3","volume":"53","author":"S Silberstein","year":"1999","unstructured":"Silberstein S, Merriam G (1999) Sex hormones and headache 1999 (menstrual migraine). Neurology 53:S3\u201313.","journal-title":"Neurology"},{"key":"2219_CR5","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s10194-023-01664-4","volume":"24","author":"B Raffaelli","year":"2023","unstructured":"Raffaelli B, Do TP, Chaudhry BA et al. (2023) Menstrual migraine is caused by estrogen withdrawal: revisiting the evidence. J Headache Pain 24:131. https:\/\/doi.org\/10.1186\/s10194-023-01664-4.","journal-title":"J Headache Pain"},{"key":"2219_CR6","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s10194-015-0503-y","volume":"16","author":"JM Pavlovi\u0107","year":"2015","unstructured":"Pavlovi\u0107 JM, Stewart WF, Bruce CA et al. (2015) Burden of migraine related to menses: results from the AMPP study. J Headache Pain 16:24. https:\/\/doi.org\/10.1186\/s10194-015-0503-y.","journal-title":"J Headache Pain"},{"key":"2219_CR7","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s10194-024-01848-6","volume":"25","author":"C-W Khoo","year":"2024","unstructured":"Khoo CC-W, Liu C-C, Lu M et al. (2024) Acute and preventive treatment of menstrual migraine: a meta-analysis. J Headache Pain 25:143. https:\/\/doi.org\/10.1186\/s10194-024-01848-6.","journal-title":"J Headache Pain"},{"key":"2219_CR8","doi-asserted-by":"publisher","unstructured":"Brown J, Lewis M, Jenkins A et al. (2024) Prevalence and characteristics of women with menstrual migraine in the 2021 United States National Health & Wellness Survey (S22.002). Neurology 102:6222. https:\/\/doi.org\/10.1212\/WNL.0000000000206329.","DOI":"10.1212\/WNL.0000000000206329"},{"key":"2219_CR9","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/s12905-022-01760-8","volume":"22","author":"W Luo","year":"2022","unstructured":"Luo W, Cao X, Zhao J et al. (2022) Health-related quality of life and associated factors in Chinese menstrual migraine patients: a cross-sectional study. BMC Womens Health 22:177. https:\/\/doi.org\/10.1186\/s12905-022-01760-8.","journal-title":"BMC Womens Health"},{"key":"2219_CR10","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1007\/s00415-020-09726-2","volume":"268","author":"LM Cupini","year":"2021","unstructured":"Cupini LM, Corbelli I, Sarchelli P (2021) Menstrual migraine: what it is and does it matter? J Neurol 268:2355\u20132363. https:\/\/doi.org\/10.1007\/s00415-020-09726-2.","journal-title":"J Neurol"},{"key":"2219_CR11","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s11910-020-01067-x","volume":"20","author":"T Ansari","year":"2020","unstructured":"Ansari T, Lagman-Bartolome AM, Monsour D, Lay C (2020) Management of menstrual migraine. Curr Neurol Neurosci Rep 20:45. https:\/\/doi.org\/10.1007\/s11910-020-01067-x.","journal-title":"Curr Neurol Neurosci Rep"},{"key":"2219_CR12","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1046\/j.1526-4610.2003.03069.x","volume":"43","author":"M Iigaya","year":"2003","unstructured":"Iigaya M, Sakai F, Kolodner KB et al. (2003) Reliability and validity of the Japanese Migraine Disability Assessment (MIDAS) questionnaire. Headache J Head Face Pain 43:343\u2013352. https:\/\/doi.org\/10.1046\/j.1526-4610.2003.03069.x.","journal-title":"Headache J Head Face Pain"},{"key":"2219_CR13","doi-asserted-by":"publisher","first-page":"422","DOI":"10.4065\/84.5.422","volume":"84","author":"DC Buse","year":"2009","unstructured":"Buse DC, Rupnow MFT, Lipton RB (2009) Assessing and managing all aspects of migraine: migraine attacks, migraine-related functional impairment, common comorbidities, and quality of life. Mayo Clin Proc 84:422\u2013435. https:\/\/doi.org\/10.4065\/84.5.422.","journal-title":"Mayo Clin Proc"},{"key":"2219_CR14","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1023\/B:QURE.0000040787.20364.89","volume":"13","author":"S Ohbu","year":"2004","unstructured":"Ohbu S, Igarashi H, Okayasu H et al. (2004) Development and testing of the Japanese version of the migraine-specific quality of life instrument. Qual of Life Res 13:1489\u20131493. https:\/\/doi.org\/10.1023\/B:QURE.0000040787.20364.89.","journal-title":"Qual Of Life Res"},{"key":"2219_CR15","first-page":"449","volume":"21","author":"F Sakai","year":"2004","unstructured":"Sakai F, Fukuuchi Y, Iwata M (2004) Reliability and validity of the Japanese version of the migraine quality of life survey [in Japanese]. Neurol Ther 21:449\u2013458.","journal-title":"Neurol Ther"},{"key":"2219_CR16","doi-asserted-by":"publisher","first-page":"353","DOI":"10.2165\/00019053-199304050-00006","volume":"4","author":"MC Reilly","year":"1993","unstructured":"Reilly MC, Zbrozek AS, Dukes EM (1993) The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics 4:353\u2013365. https:\/\/doi.org\/10.2165\/00019053-199304050-00006.","journal-title":"Pharmacoeconomics"},{"key":"2219_CR17","doi-asserted-by":"publisher","first-page":"3661","DOI":"10.1002\/sim.6607","volume":"34","author":"PC Austin","year":"2015","unstructured":"Austin PC, Stuart EA (2015) Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies. Stat Med 34:3661\u20133679. https:\/\/doi.org\/10.1002\/sim.6607.","journal-title":"Stat Med"},{"key":"2219_CR18","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s10194-020-1084-y","volume":"21","author":"DC Buse","year":"2020","unstructured":"Buse DC, Reed ML, Fanning KM et al. (2020) Comorbid and co-occurring conditions in migraine and associated risk of increasing headache pain intensity and headache frequency: results of the migraine in America symptoms and treatment (mast) study. J Headache Pain 21:23. https:\/\/doi.org\/10.1186\/s10194-020-1084-y.","journal-title":"J Headache Pain"},{"key":"2219_CR19","doi-asserted-by":"publisher","first-page":"e2313235","DOI":"10.1001\/jamanetworkopen.2023.13235","volume":"6","author":"MA Chalmer","year":"2023","unstructured":"Chalmer MA, Kogelman LJA, Ullum H et al. (2023) Population-based characterization of menstrual migraine and proposed diagnostic criteria. JAMA Netw Open 6:e2313235. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.13235.","journal-title":"JAMA Netw Open"},{"key":"2219_CR20","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s10194-023-01625-x","volume":"24","author":"H Zhang","year":"2023","unstructured":"Zhang H, Qi J-Z, Zhang Z-H (2023) Comparative efficacy of different treatments for menstrual migraine: a systematic review and network meta-analysis. J Headache Pain 24:81. https:\/\/doi.org\/10.1186\/s10194-023-01625-x.","journal-title":"J Headache Pain"},{"key":"2219_CR21","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1113\/jphysiol.1974.sp010446","volume":"236","author":"J Downie","year":"1974","unstructured":"Downie J, Poyser NL, Wunderlich M (1974) Levels of prostaglandins in human endometrium during the normal menstrual cycle. J Physiol 236:465\u2013472. https:\/\/doi.org\/10.1113\/jphysiol.1974.sp010446.","journal-title":"J Physiol"},{"key":"2219_CR22","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1111\/j.1526-4610.2004.04033.x","volume":"44","author":"RL Von Seggern","year":"2004","unstructured":"Von Seggern RL, Mannix LK, Adelman JU (2004) Rofecoxib in the prevention of perimenstrual migraine: an open-label pilot trial. Headache J Head Face Pain 44:160\u2013165. https:\/\/doi.org\/10.1111\/j.1526-4610.2004.04033.x.","journal-title":"Headache J Head Face Pain"},{"key":"2219_CR23","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/S1474-4422(20)30482-8","volume":"20","author":"KG Vetvik","year":"2021","unstructured":"Vetvik KG, MacGregor EA (2021) Menstrual migraine: a distinct disorder needing greater recognition. Lancet Neurol 20:304\u2013315. https:\/\/doi.org\/10.1016\/S1474-4422(20)30482-8.","journal-title":"The Lancet Neurol"},{"key":"2219_CR24","doi-asserted-by":"publisher","first-page":"3385","DOI":"10.3390\/molecules29143385","volume":"29","author":"M Fila","year":"2024","unstructured":"Fila M, Przyslo L, Derwich M et al. (2024) The TRPA1 ion channel mediates oxidative stress-related migraine pathogenesis. Molecules 29:3385. https:\/\/doi.org\/10.3390\/molecules29143385.","journal-title":"Molecules"},{"key":"2219_CR25","doi-asserted-by":"publisher","unstructured":"Puledda F, Sacco S, Diener H-C et al. (2024) International Headache Society global practice recommendations for the acute pharmacological treatment of migraine. Cephalalgia 44. https:\/\/doi.org\/10.1177\/03331024241252666.","DOI":"10.1177\/03331024241252666"},{"key":"2219_CR26","doi-asserted-by":"publisher","first-page":"643","DOI":"10.3390\/neurolint16030048","volume":"16","author":"Y Shibata","year":"2024","unstructured":"Shibata Y, Sato H, Sato A, Harada Y (2024) Efficacy of lasmiditan as a secondary treatment for migraine attacks after unsuccessful treatment with a triptan. Neurol Int 16:643\u2013652. https:\/\/doi.org\/10.3390\/neurolint16030048.","journal-title":"Neurol Int"},{"key":"2219_CR27","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1046\/j.1468-2982.2000.00112.x","volume":"20","author":"F Granella","year":"2000","unstructured":"Granella F, Sances G, Pucci E et al. (2000) Migraine with aura and reproductive life events: a case control study. Cephalalgia 20:701\u2013707. https:\/\/doi.org\/10.1046\/j.1468-2982.2000.00112.x.","journal-title":"Cephalalgia"},{"key":"2219_CR28","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1046\/j.1468-2982.2003.00516.x","volume":"23","author":"E Couturier","year":"2003","unstructured":"Couturier E, Bomhof M, Neven AK, van Duijn N (2003) Menstrual migraine in a representative Dutch population sample: prevalence, disability and treatment. Cephalalgia 23:302\u2013308. https:\/\/doi.org\/10.1046\/j.1468-2982.2003.00516.x.","journal-title":"Cephalalgia"},{"key":"2219_CR29","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1111\/head.14488","volume":"63","author":"IE Verhagen","year":"2023","unstructured":"Verhagen IE, van der Arend BWH, van Casteren DS et al. (2023) Sex differences in migraine attack characteristics: a longitudinal E-diary study. Headache J Head Face Pain 63:333\u2013341. https:\/\/doi.org\/10.1111\/head.14488.","journal-title":"Headache J Head Face Pain"},{"key":"2219_CR30","doi-asserted-by":"publisher","first-page":"e1661","DOI":"10.1212\/WNL.0000000000012723","volume":"97","author":"DS van Casteren","year":"2021","unstructured":"van Casteren DS, Verhagen IE, van der Arend BWH et al. (2021) Comparing perimenstrual and nonperimenstrual migraine attacks using an e-diary. Neurology 97:e1661\u2013e1671. https:\/\/doi.org\/10.1212\/WNL.0000000000012723.","journal-title":"Neurology"},{"key":"2219_CR31","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1177\/0333102411410612","volume":"31","author":"A Saisu","year":"2011","unstructured":"Saisu A, Tatsumoto M, Hoshiyama E et al. (2011) Evaluation of olfaction in patients with migraine using an odour stick identification test. Cephalalgia 31:1023\u20131028. https:\/\/doi.org\/10.1177\/0333102411410612.","journal-title":"Cephalalgia"}],"container-title":["The Journal of Headache and Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-025-02219-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10194-025-02219-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-025-02219-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T12:01:37Z","timestamp":1764244897000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejournalofheadacheandpain.biomedcentral.com\/articles\/10.1186\/s10194-025-02219-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,26]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2219"],"URL":"https:\/\/doi.org\/10.1186\/s10194-025-02219-5","relation":{},"ISSN":["1129-2377"],"issn-type":[{"value":"1129-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,26]]},"assertion":[{"value":"17 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study data were managed in accordance with Japan\u2019s Personal Information Protection Law. The study was conducted following approval from the ethics committee of the MINS (a specified nonprofit organization; approval ID: MINS-REC-240229). Patient consent was obtained before study participation, and participants were allowed to withdraw their consent at any time by contacting the Macromill Monitor Support System without disclosing the reason.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"TT is a consultant\/advisor and\/or serves on advisory boards for Eli Lilly, Otsuka, Amgen, Pfizer, and Teijin; has received speaker honoraria from Daiichi Sankyo, Eli Lilly, Otsuka, Amgen, Sawai, Eisai, and Takeda; and has received grants\/funding from Eli Lilly, Pfizer, and Tsumura outside the submitted work. KI has no competing interests to disclose. RY, KT, TK, and MI are employees of Pfizer Japan Inc. KT and MI are shareholders of Pfizer Inc.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"276"}}